Carregant...
HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients
The inability of patients with CVID to mount specific antibody responses to pathogens has raised concerns on the risk and severity of SARS-CoV-2 infection, but there might be a role for protective T cells in these patients. SARS-CoV-2 reactive T cells have been reported for SARS-CoV-2 unexposed heal...
Guardat en:
| Publicat a: | Front Immunol |
|---|---|
| Autors principals: | , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7785785/ https://ncbi.nlm.nih.gov/pubmed/33424856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.607918 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|